CareDx provides transplant testing, donor matching products, software and pharmacy services for transplant centers and patients. Over the past 90 days StreetAlpha recorded 1 whale options trade in CDNA, 0% of them bullish and 100% bearish. In the past 30 days there were 3 dark pool prints.
Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 30 | BTIG | Target raised | Buy | |
| Oct 27 | BTIG | Target raised | Buy | |
| Oct 19 | Canaccord Genuity | Target raised | Buy | |
| Sep 24 | BTIG | Target raised | Buy | |
| Sep 2 | Canaccord Genuity | Initiated | Buy |
Whale Options Flow
90DNo whale options trades in CDNA in the last 90 days.
Dark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CDNA is in one of them and how their past CDNA trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered CDNA in an article yet. Here's the latest on the wider market.
CDNA Congress Trades
All congress trades →
| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Dan GoldmanD · NY | Sell | $1K – $15K | Mar 6, 2023 | Apr 17, 2023 | 42 d |
| Tom MalinowskiD · NJ | Buy | $15K – $50K | Mar 2, 2021 | Apr 10, 2021 | 39 d |
| Tom MalinowskiD · NJ | Sell | $1K – $15K | Jun 19, 2019 | Mar 5, 2021 | 625 d |
| Tom MalinowskiD · NJ | Sell | $1K – $15K | Jun 17, 2019 | Mar 5, 2021 | 627 d |
| Tom MalinowskiD · NJ | Buy | $1K – $15K | Apr 1, 2019 | Mar 5, 2021 | 704 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About CareDx
CareDx is a company that offers testing and software for transplant patients and the clinicians who treat them. Its tests check heart, kidney and lung transplant recipients for signs of organ rejection after surgery. The company also sells products that help match donors and recipients before a transplant, software that helps transplant centers manage patient lists and workflow, and specialized pharmacy services for transplant patients. Its main customers are transplant centers, and it is based in Brisbane, California.
- Headquarters
- Brisbane, CA
- Founded
- 2000
- Website
- caredx.com ↗